QA: Aptinyx Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001674365_2019_Aptinyx_Inc.pdf

Logs

Graph

Absolute values for 0001674365, Aptinyx Inc.

  xvar xval
0 AssetsCurrent 153,251,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,690,000
3 remainder_Assets 673,000
4 LiabilitiesCurrent 5,885,000
5 LiabilitiesNoncurrent 418,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,674,000
9 ResearchAndDevelopmentExpense 48,788,000
10 remainder_Expenses 0
11 remainder_Revenues 6,574,000
12 remainder_NetIncome 1,607,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 155,614,000
1 Liabilities 6,303,000
2 Expenses 61,462,000
3 Revenues 6,574,000
4 StockholdersEquity 149,311,000
5 NetIncome -53,281,000
6 ComprehensiveNetIncome -53,281,000
7 BaseVar 115,780,000
8 EconomicCapitalRatio 2.51

Edgar->Model Mapping

Feature Distribution

Change over Time